Delivery Order SPE2DR25D3201-SPE2DR26FT4CK
Award Date 11/18/25
Potential Completion Date 11/19/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a $2,792.25 delivery order by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025, for the supply of Micafungin 100 mg vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MICAFUNGIN 100 MG/100-0.9%NACL 100ML medical supplies. The award, valued at $1,350.59, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 7, 2025. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,775.46 firm fixed-price delivery order is for the supply of 100 mg MICAFUNGIN vials. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare systems. This competitively awarded, non-set-aside contract is valued at $16,184.74 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,099.14 with an ultimate completion date of August 25, 2025. The contract was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $57,139.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (valued at $999,999,999.00 and running through December 2026) with DLA Troop Support Medical. The delivery order is designated for the Pharmaceutical Prime Vendor Division and...
- The Defense Logistics Agency awarded a $1,346.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials. This contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $12,688.46 to AmerisourceBergen Drug Corp on October 20, 2025, for pharmaceutical products and medical supplies. This firm fixed price delivery order, which is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), represents a non-competitive set-aside transaction. The work will be performed at AmerisourceBergen's corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $18,672.30 to AmerisourceBergen Drug Corp on August 1, 2025, with a completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical and...